White House Seeks Pharma Support for Drug Pricing Bill

White House officials have drafted legislative text for their drug pricing policy. According to people familiar with the meetings, this draft is being shared with over a dozen major pharmaceutical companies. The main goal is to secure support for the proposal at a crucial time. The administration seeks to finalize health reforms, with a special emphasis on the affordability of medicines, a central theme on the president's agenda in this election year.

The legislative draft closely follows the outlines of the voluntary deals the administration has negotiated with pharmaceutical companies. This includes a policy that would allow drugs purchased in cash to count toward the patient's deductible. The Trump administration's initiative is part of a broader effort to get health reforms signed into law.

A White House official confirmed that the legislative draft closely follows the outlines of the voluntary agreements the administration has already established with pharmaceutical companies. This strategy seeks to capitalize on existing relationships and secure broader consensus. The inclusion of the policy on the use of cash purchases for the deductible is a key point.

The Trump administration is pushing this legislation as part of a broader strategy to achieve health reforms. The president's focus on the affordability of medicines, especially in an election year, has raised the profile of this effort.

The Trump administration is pushing drug pricing legislation as part of a broader effort to achieve health reforms. The president's focus on his affordability agenda in an election year has increased the visibility of this effort. The White House seeks to ensure that this legislation is passed and signed, which could have a significant impact on access to and the cost of medicines for citizens.

Collaboration with pharmaceutical companies is crucial for the success of this initiative. The administration hopes that by aligning the legislation with previous agreements and addressing aspects such as the deductible, a favorable consensus can be built.